Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- MYR Group: Stronger Bull Case, but the Bear Case Stays
- AtriCure: Stronger Bull Case, but the Bear Case Stays
- City: One Side Has 4 Points, the Other 3
- MannKind and the Split Between 6 Bulls and 8 Bears
- What the Data Says For and Against International Money Express, Inc. (IMXI)
- The Bulls Have More to Work With for Ocular Therapeutix as the Counts Stack Up
- UroGen Pharma Has 8 Bulls and 1 Bears to Sort Through
- Middlesex Water: What the Bull-Bear Split Adds Up to
- Kelly Services in the Numbers: The Bulls Have More to Work With
- Encore Capital Sets Up an 8-Point Bull Case Against a 2-Point Bear Case
- Primoris Services: Why the Case Still Cuts Both Ways
- Community West Bancshares Sets Up a 5-Point Bull Case Against a 5-Point Bear Case
- FirstService Has 3 Bulls and 5 Bears to Sort Through
- Melco Resorts & Entertainment: More Bulls Than Bears in the Dossier
- Fidus Investment After the Filings: The Bulls Have More to Work With
- Equity Bancshares: The Bulls Have More to Work With After the Latest Review
- Jack in the Box in the Numbers: An Evenly Argued Case
- The Bull and Bear Case for Grupo Financiero Galicia S.A. (GGAL): 7 Points Against 7
- Capital City Bank With The Bulls Have More to Work With and a Bear Case Still Standing
- Home Bancshares Draws Both Sides as The Bulls Have More to Work With
- Gravity Has a Clearer Bull Side, but a Bear Side Too
- What the Data Says For and Against Bel Fuse Inc. (BELFA)
- ICU Medical: How the Bull and Bear Lists Compare
- What the Data Says For and Against OraSure Technologies, Inc. (OSUR)
- L.B. Foster: An Evenly Argued Case After the Latest Review
- Erie Indemnity: A Mixed Record, With Bulls Holding More Cards
- Silicon Laboratories: More Bulls Than Bears in the Dossier
- Oramed Pharmaceuticals Looks Split by Count, Not by Certainty
- Astronics: Why the Case Still Cuts Both Ways
- Supernus Pharmaceuticals Has 7 Bulls and 5 Bears to Sort Through
- Sinclair After the Filings: An Evenly Argued Case
- Ligand Pharmaceuticals: Stronger Bull Case, but the Bear Case Stays
- Republic Bancorp Draws Both Sides as The Bulls Have More to Work With
- Omnicell Sees the Argument Tilt Toward Bullish
- Timberland Bancorp Draws a Bullish Lean From the Lists
- Napco Security Technologies: Why the Case Still Cuts Both Ways
- What the Data Says For and Against Peoples Financial Services Corp. (PFIS)
- What the Data Says For and Against Fulgent Genetics, Inc. (FLGT)
- Northwest Bancshares: Stronger Bull Case, but the Bear Case Stays
- Axcelis Technologies Sets Up a 7-Point Bull Case Against a 6-Point Bear Case
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with